Bioinformatics analysis of differentially expressed genes in hepatocellular carcinoma cells exposed to Swertiamarin
Bioinformatics analysis of differentially expressed genes in hepatocellular carcinoma cells exposed to Swertiamarin
复制标题
獐牙菜苷染毒肝细胞癌细胞差异表达基因的生物信息学分析
DOI:
10.7150/jca.33666
复制
发表时间:
2019-10
期刊:
影响因子:
--
通讯作者:
Jijun Chen
中科院分区:
文献类型:
--
作者:
Haoran Tang;Yang Ke;Zongfang Ren;Xuefen Lei;Shufeng Xiao;Tianhao Bao;Zhitian Shi;Renchao Zou;Tiangen Wu;Jian Zhou;Chang-An Geng;Lin Wang;Jijun Chen
Aim: To explore gene expression profiling in hepatocellular carcinoma (HCC) cells exposed to swertiamarin. Methods: Cell viability, apoptosis and invasion were examined in HepG2 cells after swertiamarin treatment. Tumor growth of SK-Hep-1 cells xenografted in nude mice was monitored after swertiamarin treatment. Total RNA was isolated from HepG2 cells treated with swertiamarin for microarray analysis. The data of microarray were analyzed by bioinformatics. Results: Swertiamarin treatment decreased the viability and invasion while increased the apoptosis of HepG2 cells, and significantly inhibited the growth of SK-Hep-1 cells xenografted in nude mice. Pathway and biological process analysis of differentially expressed genes (DEGs) in swertiamarin treated HepG2 cells showed that PI3k-Akt was the most significant regulated pathway. 47 targets of swertiamarin were predicted by CGBVS while 21 targets were predicted by 3NN. Notably, 8 targets were predicted as the targets of swertiamarin by both programs, including two prominent targets JUN and STAT3. A large range of DEGs induced by swertiamarin could be regulated by JUN and STAT3. Conclusion: Swertiamarin treatment led to significant changes in the expression of a variety of genes that modulate cell survival, cell cycle progression, apoptosis, and invasion. Moreover, most of these genes can be clustered into pathway networks such as PI3K, JUN, STAT3, which are predicted targets of swertiamarin. Further confirmation of these targets will reveal the anti-tumor mechanisms of swertiamarin and facilitate the development of swertiamarin as a novel agent for cancer prevention and treatment.
登录
查看更多内容
影响因子:
8.6
作者:
Liu X;Xu Y;Li S;Wang Y;Peng J;Luo C;Luo X;Zheng M;Chen K;Jiang H
通讯作者:
Jiang H
影响因子:
--
作者:
Hanumesh Vaidya;S. Giri;M. Jain;R. Goyal
通讯作者:
Hanumesh Vaidya;S. Giri;M. Jain;R. Goyal
影响因子:
1.2
作者:
S. Soltanian;Helia Riahirad;Athareh Pabarja;M. Karimzadeh;Kolsoum Saeidi
通讯作者:
S. Soltanian;Helia Riahirad;Athareh Pabarja;M. Karimzadeh;Kolsoum Saeidi
影响因子:
3.6
作者:
Hamanaka, Masatoshi;Taneishi, Kei;Okuno, Yasushi
通讯作者:
Okuno, Yasushi
影响因子:
1.2
作者:
H. Ye;Weiwei Wang;Yu Ding;Xiaoli Liu;Jia Wenji;W. Luo;Hui‐Fen Fan;Hong-She Zhou;Jin Wang;Jianlong Ju;Dongming Zhou;T. Bao;Yu-hong Zhu
通讯作者:
H. Ye;Weiwei Wang;Yu Ding;Xiaoli Liu;Jia Wenji;W. Luo;Hui‐Fen Fan;Hong-She Zhou;Jin Wang;Jianlong Ju;Dongming Zhou;T. Bao;Yu-hong Zhu